Get started
Author

R. de Francisco García

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
2019 · María Chaparro, María G. Donday, et al. · Therapeutic Advances in Gastroenterology · 7
Manejo extra-hospitalario de la enfermedad inflamatoria intestinal: papel de Atención Primaria
2012 · S. Riestra Menéndez, R. de Francisco García, et al. · Medicine - Programa de Formación Médica Continuada Acreditado · 5
P1271 The Astur-Frailty-IBD Study: Prevalence and factors associated with Frailty in elderly patients with Inflammatory Bowel Disease.
2025 · L Carballo-Folgoso, J M Duque Alcorta, et al. · Journal of Crohn s and Colitis
P1274 The Astur-Frailty-IBD Study: Assessment of Frailty in elderly IBD patients and comparison of four frailty scores.
2025 · L Carballo-Folgoso, J M Duque Alcorta, et al. · Journal of Crohn s and Colitis
P410 Long-term persistence and safety of biological drugs in patients with Inflammatory Bowel Disease. Differences between women and men: SEXEII study of ENEIDA
2023 · C Gargallo-Puyuelo, E Ricard, et al. · Journal of Crohn s and Colitis
Despistaje de la tuberculosis en la EII
2012 · S. Riestra Menéndez, R. de Francisco García, et al. · Dialnet (Universidad de la Rioja)
Differences between pediatric and adult celiac disease Diferencias entre la enfermedad celiaca infantil y del adulto
2011 · Luis Rodrigo Sáez, D. Fuentes Álvarez, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Works count: 8
Citation count: 12
H-index: 2
I10-index:
Year
Topic
Type